C

ResMed Inc. RMD

$218.27 -$1.31-0.60% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2026 03/31/2026 12/31/2025 09/30/2025 06/30/2025
Net Income 1.52B 1.52B 1.49B 1.44B 1.40B
Total Depreciation and Amortization 218.64M 237.75M 220.80M 214.36M 210.34M
Total Amortization of Deferred Charges 25.51M 25.57M 25.40M 25.41M 25.47M
Total Other Non-Cash Items 112.63M 114.20M 108.43M 104.30M 98.32M
Change in Net Operating Assets -74.24M -7.12M 74.00M 101.39M 16.74M
Cash from Operations 1.81B 1.89B 1.91B 1.88B 1.75B
Capital Expenditure -156.29M -135.74M -122.89M -114.99M -89.87M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -350.72M -163.98M -139.10M -139.77M -139.25M
Divestitures -- -- -- -- --
Other Investing Activities -38.19M 4.47M -7.03M -9.00K 29.07M
Cash from Investing -545.20M -295.26M -269.02M -254.77M -200.05M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -10.00M -10.00M -10.00M -10.00M -40.00M
Issuance of Common Stock 74.50M 75.35M 76.94M 74.26M 74.44M
Repurchase of Common Stock -721.87M -622.08M -522.04M -418.44M -318.10M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -349.66M -340.16M -330.63M -320.74M -310.88M
Other Financing Activities -- -10.86M -10.86M -10.86M -11.71M
Cash from Financing -1.01B -907.75M -796.58M -685.77M -606.25M
Foreign Exchange rate Adjustments 6.18M 40.85M 46.23M 14.66M 25.80M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 259.78M 727.80M 895.13M 957.49M 971.09M